Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03146078 · ClinicalTrials.gov registry record
Rate of Progression in USH2A-related Retinal Degeneration
A clinical trial of Usher Syndrome, Type 2A and Retinitis Pigmentosa 39, sponsored by Jaeb Center for Health Research.
- Active
- Registry status
- 127
- Enrollment target
- 14
- Study locations
NCT03146078 is a study of Usher Syndrome, Type 2A and Retinitis Pigmentosa 39 that is active but no longer recruiting, run by Jaeb Center for Health Research. The registered enrollment target is 127 participants. The trial reports 14 study locations across 9 states.
The verdict
NCT03146078, a study of Usher Syndrome, Type 2A and Retinitis Pigmentosa 39, is active but no longer recruiting, sponsored by Jaeb Center for Health Research.
- ACTIVE NOT RECRUITING
- Registry status
- 127 participants
- Enrollment target
- 14
- Study locations
Study Summary
The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with USH2A related retinal degeneration associated with congenital hearing loss (Usher syndrome type 2a) or non-syndromic retinitis pigmentosa (RP39). RUSH2A Extension Study: The purpose of this addendum is to extend RUSH2A to 7- and 9-year visits, with the goal to use longer term data to further develop and support early candidate endpoints as possible clinical trial outcomes.
Conditions Studied
Study Locations (14)
Other
- Hospital for Sick Children - Toronto
- Centre hospitalier National d'Ophtalmologie des Quinze-Vingts - Paris
- University of Tubingen - Tübingen
- Radboud University - Nijmegen
- Moorfields Eye Hospital - London
Texas
- Retina Foundation of the Southwest - Dallas
- Baylor Eye Physicians and Surgeons - Houston
California
- University of California, San Francisco - San Francisco
Florida
- Vitreo-Retinal Associates - Gainesville
Maryland
- Wilmer Eye Institute at Johns Hopkins - Baltimore
Massachusetts
- Massachusetts Eye and Ear - Boston
Michigan
- Kellogg Eye Center, University of Michigan - Ann Arbor
Oregon
- OHSU Casey Eye Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2017-08-11 |
| Est. Completion | 2029-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03146078
The ClinicalTrials.gov registry entry for NCT03146078 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jaeb Center for Health Research, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Usher Syndrome, Type 2A appearing as the primary indexed condition, and to 0 interventions.
NCT03146078 reports 14 study locations spanning 9 distinct geographic areas - top geographies include Other, Texas, California.
Frequently Asked Questions
What is clinical trial NCT03146078 about?
NCT03146078 is a clinical study titled "Rate of Progression in USH2A-related Retinal Degeneration". The overall goal of this project funded by the Foundation Fighting Blindness is to characterize the natural history of disease progression in patients with USH2A related retinal degeneration associated with congenital hearing loss (Usher syndrome type 2a) or non-syndromic retinitis pigmentosa (RP39)...
What is the current status of trial NCT03146078?
This trial is currently active not recruiting. The enrollment target is 127 participants. The study started on 2017-08-11. Estimated completion is 2029-12.
What conditions does trial NCT03146078 study?
This clinical trial studies the following conditions: Usher Syndrome, Type 2A, Retinitis Pigmentosa 39.
Who is sponsoring clinical trial NCT03146078?
This trial is sponsored by Jaeb Center for Health Research, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03146078 being conducted?
This trial has 14 study locations across California, Florida, Maryland, Massachusetts, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.